E-ISSN: 2619-9467

Contents    Cover    Publication Date: 24 Dec 2020
Year 2020 - Volume 30 - Issue 4

Open Access

Peer Reviewed

CASE REPORTS
594 Viewed496 Downloaded

Neurofibromatosis and Pregnancy

  
J Clin Obstet Gynecol. 2020;30(4):153-6
DOI: 10.5336/jcog.2020-78717
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Neurofibromatosis (NF) is an autosomal dominant genetic syndrome which can be seen in 1: 3000- 1:5000 women. Women with NF without infertility problem may have one or more pregnancies during reproductive years. Pregnancies of patients with neurofibromatosis are known to be complicated by intrauterine growth retardation, preterm birth, gestational hypertension and preeclampsia, but history of abruption is very rare in few cases. Physicians should be aware of the complications of this unique pregnancy and manage it multidisciplinary. The purpose of this case report is to share the experience of the pregnancy with neurofibromatosis, having epilepsy and unexplained embolism history, which is complicated with intrauterine growth retardation and placental abruption.
REFERENCES:
  1. Segal D, Holcberg G, Sapir O, Sheiner E, Mazor M, Katz M. Neurofibromatosis in pregnancy. Maternal and perinatal outcome. Eur J Obstet Gynecol Reprod Biol. 1999;84(1):59-61.[Crossref] [PubMed] 
  2. Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet. 1996;66(1):7-10.[Crossref] [PubMed] 
  3. Chetty SP, Shaffer BL, Norton ME. Management of pregnancy in women with genetic disorders: Part 2: Inborn errors of metabolism, cystic fibrosis, neurofibromatosis type 1, and Turner syndrome in pregnancy. Obstet Gynecol Surv. 2011;66(12):765-7.[Crossref] [PubMed] 
  4. Terry AR, Barker FG 2nd, Leffert L, Bateman BT, Souter I, Plotkin SR. Neurofibromatosis type 1 and pregnancy complications: a population-based study. Am J Obstet Gynecol. 2013;209(1):46.e1-8.[Crossref] [PubMed] 
  5. Friedman JM. Neurofibromatosis 1. 1998 Oct 2 [Updated 2019 Jun 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: [Link] 
  6. Hadi HA. Clinical significance of neurofibromatosis in pregnancy. Am J Perinatol. 1995;12(6):459-61.[Crossref] [PubMed] 
  7. Leppävirta J, Kallionpää RA, Uusitalo E, Vahlberg T, Pöyhönen M, Timonen S, et al. The pregnancy in neurofibromatosis 1: a retrospective register-based total population study. Am J Med Genet A. 2017;173(10):2641-8.[Crossref] [PubMed] 
  8. Sharma JB, Gulati N, Malik S. Maternal and perinatal complications in neurofibromatosis during pregnancy. Int J Gynaecol Obstet. 1991;34(3):221-7.[Crossref] [PubMed] 
  9. Agarwal U, Dahiya P, Sangwan K. Recent onset neurofibromatosis complicating eclampsia with maternal death: a case report. Arch Gynecol Obstet. 2003;268(3):241-242.[Crossref] [PubMed] 
  10. Hagymásy L, Tóth M, Szücs N, Rigó J Jr. Neurofibromatosis type 1 with pregnancy-associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol. 1998;179(1):272-4.[Crossref] [PubMed] 
  11. Njei B, Sanchez H. Neurofibromatosis type 1, recurrent pulmonary embolism, and a periampullary carcinoid tumor: is there a link? Conn Med. 2013;77(2):77-80.[PubMed] 
  12. Tomson T, Battino D, Perucca E. Teratogenicity of antiepileptic drugs. Curr Opin Neurol. 2019;32(2):246-52.[Crossref] [PubMed] 
  13. Melamed N, Aviram A, Silver M, Peled Y, Wiznitzer A, Glezerman M, et al. Pregnancy course and outcome following blunt trauma. J Matern Fetal Neonatal Med. 2012;25(9):1612-7.[Crossref] [PubMed] 
  14. Cesaretti C, Melloni G, Quagliarini D, Fogliani R, Zaina B, Bedeschi MF, et al. Neurofibromatosis type 1 and pregnancy: maternal complications and attitudes about prenatal diagnosis. Am J Med Genet A. 2013;161A(2):386-8.[Crossref] [PubMed]